These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24527460)

  • 21. IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model.
    Gomez-Cabrero A; Wrasidlo W; Reisfeld RA
    PLoS One; 2013; 8(8):e73607. PubMed ID: 24014113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
    Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
    Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
    Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
    Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells.
    Lee HC; Ling QD; Yu WC; Hung CM; Kao TC; Huang YW; Higuchi A
    Drug Des Devel Ther; 2013; 7():491-502. PubMed ID: 23818760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.
    Wang L; Guo H; Lin C; Yang L; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2117-23. PubMed ID: 24676900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
    Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
    Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.
    Colak S; Zimberlin CD; Fessler E; Hogdal L; Prasetyanti PR; Grandela CM; Letai A; Medema JP
    Cell Death Differ; 2014 Jul; 21(7):1170-7. PubMed ID: 24682005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cell theory: therapeutic implications for nanomedicine.
    Wang K; Wu X; Wang J; Huang J
    Int J Nanomedicine; 2013; 8():899-908. PubMed ID: 23467584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
    Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
    BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells.
    Shen C; Yang C; Xia B; You M
    Cancer Lett; 2021 Mar; 500():244-252. PubMed ID: 33242560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.
    Zanotti L; Romani C; Tassone L; Todeschini P; Tassi RA; Bandiera E; Damia G; Ricci F; Ardighieri L; Calza S; Marchini S; Beltrame L; Tognon G; D'Incalci M; Pecorelli S; Sartori E; Odicino F; Ravaggi A; Bignotti E
    BMC Cancer; 2017 May; 17(1):366. PubMed ID: 28545541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
    Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
    Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.
    Makena MR; Ranjan A; Thirumala V; Reddy AP
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165339. PubMed ID: 30481586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance.
    Ward Rashidi MR; Mehta P; Bregenzer M; Raghavan S; Fleck EM; Horst EN; Harissa Z; Ravikumar V; Brady S; Bild A; Rao A; Buckanovich RJ; Mehta G
    Neoplasia; 2019 Aug; 21(8):822-836. PubMed ID: 31299607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can nanomedicines kill cancer stem cells?
    Zhao Y; Alakhova DY; Kabanov AV
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.